Secora Michael 的 Form 4 申報
Recursion Pharmaceuticals, Inc.（RXRX），2023/11/16 申報
- 申報編號
- 0001209191-23-055610
- 申報時間
- 2023/11/16
- 交易日
- 2023/11/14-11/15
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $34.1 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Secora MichaelCIK 0001855980 | 高階主管（財務長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/11/14 | Class A Common Stock | M行使選擇權取得 | +37,500 | $2.22 | +$83,250 | 950,686 | 直接 | |
| 2023/11/14 | Class A Common Stock | S賣出處分 | −25,000 | $6.32F2 | −$158,000 | 925,686 | 直接 | |
| 2023/11/15 | Class A Common Stock | M行使選擇權取得 | +37,500 | $2.22 | +$83,250 | 963,186 | 直接 | |
| 2023/11/15 | Class A Common Stock | S賣出處分 | −20,300 | $7.25F3 | −$147,175 | 942,886 | 直接 | |
| 2023/11/15 | Class A Common Stock | S賣出處分 | −4,700 | $7.62F4 | −$35,814 | 938,186 | 直接 | |
| 2023/11/15 | Class A Common Stock | F扣股繳稅處分 | −7,172 | $7.18 | −$51,494.96 | 931,014 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/11/14 | Class A Common Stock | M行使選擇權處分 | −37,500 | $0.00 | $0 | 1,222,635 | 直接 | |
| 2023/11/15 | Class A Common Stock | M行使選擇權處分 | −37,500 | $0.00 | $0 | 1,185,135 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $6.13 to $6.485. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $6.51 to $7.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $7.51 to $7.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。